Oracle's Split Personality: AI Momentum Meets a Balance Sheet Under Scrutiny
Published on 08/07/2026 at 13:12 | Redaktion boerse-global.de
The tension coursing through Oracle's stock right now is almost palpable. On one side sits a company riding the artificial intelligence wave with a string of headline-grabbing contract wins and partnership announcements. On the other, a credit profile that has rating agencies and analysts openly fretting about the cost of it all. Rarely have the bull and bear cases for a single technology giant coexisted so uncomfortably.
A Week of Catalysts
The most recent surge came on August 3, when shares jumped 9.22 percent in New York to close at $141.85 — the company's best single-day performance in months, by its own accounting. That rally didn't emerge from a vacuum. It followed a cluster of announcements: an expanded collaboration with Google Cloud that brings Alphabet's Gemini models into Oracle's Fusion Applications and NetSuite via the Oracle AI Agent Studio, a nearly $400 million contract shared with CACI International, an expansion of Oracle Health into Ontario hospitals, and the Gemini integration itself.
The CACI deal is particularly notable. It's a ten-year agreement to modernize the HR technology infrastructure of the US Office of Personnel Management, with Oracle Fusion HCM deployed as a software-as-a-service solution featuring embedded AI capabilities. Baker Tilly and Deloitte are also supporting the effort, though the award originally went directly to Oracle. Over a seven-trading-day stretch, the stock accumulated a 10.33 percent gain — a reminder of just how news-driven this equity has become.
The Credit Cloud
Yet even as the equity market celebrates, the credit market tells a more cautious story. Back on July 9, shares had touched an interim low near $131 after S&P Global Ratings downgraded Oracle's long-term creditworthiness to BBB- — just one notch above junk territory. The agency's central concern: OpenAI accounts for roughly half of Oracle's massive $638 billion backlog.
Should investors sell immediately? Or is it worth buying Oracle?
Reuters framed the situation even more starkly earlier this week, reporting that Oracle stands on the edge of a downgrade into speculative-grade territory. The issue isn't demand — it's how the company funds its ambitions. Limited cash reserves are forcing Oracle to lean heavily on debt and take on substantial long-term lease obligations.
There's also a structural element that often gets overlooked: founder Larry Ellison controls 40.6 percent of Oracle's shares and has personally guaranteed $40.4 billion for a media venture. That concentration of ownership and contingent liability adds another layer of complexity to the company's capital structure.
Analysts Split the Difference
UBS analyst Karl Keirstead captured the prevailing ambivalence on Thursday when he trimmed his price target on Oracle from $285 to $245 while maintaining a "Buy" rating. His reasoning cited heavy capital expenditures for AI infrastructure buildout and tightening conditions in the credit markets. He also pointed to the 27 percent slide the stock suffered in May after the company reported its fiscal fourth-quarter results.
Those results, delivered in early June, illustrate the fundamental tension. Cloud infrastructure revenue grew 93 percent in the quarter, total revenue rose 21 percent to $19.2 billion, and the remaining performance obligations (RPO) backlog surged 363 percent year over year to $638 billion. For the full fiscal year, Oracle posted revenue of $67.4 billion, up 17 percent, with cloud revenue climbing 39 percent to $34.0 billion.
The cost of that growth is staggering. Capital expenditures jumped 162 percent to $55.7 billion, pushing free cash flow to negative $23.7 billion. Oracle raised $43 billion in debt and $5 billion in equity last fiscal year and has announced plans for roughly $40 billion in additional capital raises this year. The company is guiding to 34 percent revenue growth and adjusted earnings per share of $8.05 for the current fiscal year — numbers that explain why growth-oriented analysts remain constructive even as the financing burden grows.
Oracle at a turning point? This analysis reveals what investors need to know now.
Military Contracts Add to the Pipeline
Beyond the OPM work, Oracle has been stacking up federal business. On July 23, the company secured a ten-year enterprise software agreement under the US Department of Defense's Enterprise Software Initiative. The base value is $3.31 billion for the first five years, with the potential to expand to $6.99 billion if all options are exercised. The contract consolidates what had been fragmented Oracle licensing across the military.
In Frankfurt on Thursday, Oracle shares closed at €124.28, down 0.58 percent from the prior session. The weekly gain of 10.33 percent in dollar terms nonetheless underscores how quickly sentiment can shift with the news cycle.
Two Narratives, One Stock
The upcoming quarterly results on September 7 and Oracle OpenWorld in late October should provide clearer signals about which story wins out. For now, the stock sits at the intersection of genuine, contract-backed AI momentum and a financing model that grows more expensive by the quarter. Investors are essentially being asked to bet on whether the backlog converts to cash faster than the debt compounds. That's a wager with considerable upside — and equally considerable downside if the credit markets lose patience first.
Ad
Oracle Stock: New Analysis - 7 August
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
